$BIIB Company News Utility stocks gain as Treasury yields

New Post Public Reply Private Reply Replies (0) Message Board

Feb 24, 2014 at 10:47 AM

$BIIB Company News

Utility stocks gain as Treasury yields lag 4:06 p.m. Feb. 4, 2014 - Wallace Witkowski
Biogen Idec investors focus on positive, ignore outlook for 2014 2:02 p.m. Jan. 29, 2014 - Russ Britt
Biogen profit jumps on MS treatment revenue 7:09 a.m. Jan. 29, 2014 - MarketWatch.com
Stock investors trash market darlings, face Apple, Fed 8:01 a.m. Jan. 26, 2014 - Wallace Witkowski
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Speculators turn the heat up to ‘soft boil’ 3:55 p.m. Jan. 16, 2014 - The Trading Deck
GameStop tumbles 20%; Tesla surges on strong sales 4:23 p.m. Jan. 14, 2014 - Sue Chang
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Biogen, Sangamo partner on hemoglobin therapies 9:39 a.m. Jan. 9, 2014 - MarketWatch.com
Earnings boost Micron, drag on Container Store 4:25 p.m. Jan. 8, 2014 - Sue Chang
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
Charting a bullish year-end backdrop 12:29 p.m. Dec. 17, 2013 - Michael Ashbaugh
Charting a bullish year-end backdrop 12:03 p.m. Dec. 17, 2013 - Michael Ashbaugh
Get your portfolio to turn the corner 2:33 p.m. Dec. 10, 2013 - The Trading Deck
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Growth stock players should reduce expectations 1:19 p.m. Nov. 26, 2013 - The Trading Deck
DaVita, Fresenius gain; energy firms slip 4:56 p.m. Nov. 25, 2013 - Ben Eisen
Stocks gain for 7th week; S&P ends above 1,800 4:24 p.m. Nov. 22, 2013 - Polya Lesova
Biogen Idec jumps; Intel, Ross Stores slide 4:23 p.m. Nov. 22, 2013 - Saumya Vaishampayan
Biogen surges 13%, best on S&P 500 9:33 a.m. Nov. 22, 2013 - Laura Mandaro

Can The Uptrend Continue for Biogen Idec (BIIB)? - Tale of the Tape 49 min ago - Zacks.com
Retrophin (RTRX) Jumps: Stock Moves 14.3% Higher - Tale of the Tape 9:46 a.m. Today - Zacks.com
Agenus (AGEN) in Focus: Stock Up 6.9% - Tale of the Tape 9:39 a.m. Today - Zacks.com
Stemline Therapeutics (STML) Worth Watching: Stock Rises 8.1% - Tale of the Tape 9:25 a.m. Today - Zacks.com
ACADIA Pharmaceuticals (ACAD) Jumps: Stock Rises 17.3% - Tale of the Tape 9:18 a.m. Today - Zacks.com
Exact Sciences (EXAS) in Focus: Stock Up 5.2% - Tale of the Tape 8:51 a.m. Today - Zacks.com
ImmunoGen, Inc. (IMGN) Catches Eye: Stock Jumps 6.3% - Tale of the Tape 8:44 a.m. Today - Zacks.com
XOMA Corporation (XOMA) in Focus: Stock Moves 11.5% Higher - Tale of the Tape 8:37 a.m. Today - Zacks.com
Acorda Therapeutics: Long-Term Fundamentals Look Promising 12:53 p.m. Feb. 22, 2014 - Seeking Alpha
OncoMed Commences Study on OMP-54F28 - Analyst Blog 4:50 p.m. Feb. 21, 2014 - Zacks.com
XenoPort's 4Q Loss Narrower-Than-Expected - Analyst Blog 11:22 a.m. Feb. 21, 2014 - Zacks.com
Synergy Pharmaceuticals, Inc. (SGYP) Looks Good: Stock Adds 8.8% in Session - Tale of the Tape 8:44 a.m. Feb. 21, 2014 - Zacks.com
Onconova's Rigosertib Misses Primary Endpoint - Analyst Blog 6:40 p.m. Feb. 20, 2014 - Zacks.com
Dynavax Withdraws MAA on Heplisav - Analyst Blog 6:20 p.m. Feb. 20, 2014 - Zacks.com
Omeros Doses First Patient in a Study - Analyst Blog 6:00 p.m. Feb. 20, 2014 - Zacks.com
Interim Data on Insmed's Arikace - Analyst Blog 5:10 p.m. Feb. 20, 2014 - Zacks.com
Biogen Idec Inc (BIIB): Today's Featured Drugs Winner 5:00 p.m. Feb. 20, 2014 - TheStreet.com
Who Is Responsible For Biotech's Torrid Start to 2014? 4:03 p.m. Feb. 20, 2014 - TheStreet.com
Insider Trading Alert - BWA, BIIB And INVN Traded By Insiders 10:45 a.m. Feb. 20, 2014 - TheStreet.com
OvaScience (OVAS) in Focus: Stock Up 5.6% - Tale of the Tape 9:39 a.m. Feb. 20, 2014 - Zacks.com

SciQuest Customers to Discuss Procurement Transformation in Action at NextLevel 2014 8:35 a.m. Today - BusinessWire - BZX
RBCC: New Innovations Spur Demand for 3D Printing in Medicine 5:00 a.m. Feb. 20, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 2014 RBC Capital Markets’ Healthcare Conference 4:01 p.m. Feb. 18, 2014 - BusinessWire - BZX
New Product Puts RBCC on Leading Edge of Organ Regeneration Research 5:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
William D. Young To Retire From Biogen Idec’s Board of Directors 1:50 p.m. Feb. 15, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 10:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
RBCC Seeks Out Capital Partners for 3D Bioprinting Expansion 5:00 a.m. Feb. 6, 2014 - BusinessWire - BZX
Cleave Biosciences Names Alessandra Cesano as Chief Medical Officer and Lewis Shuster as Director 8:00 a.m. Feb. 4, 2014 - PR Newswire - PRF
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 9:33 a.m. Feb. 3, 2014 - BusinessWire - BZX
TECFIDERA® (Dimethyl Fumarate) Approved in the European Union as a First-Line Oral Treatment for Multiple Sclerosis 8:53 a.m. Feb. 3, 2014 - BusinessWire - BZX
RBCC: 3D Bioprinting Tech Ushers in Future of Medicine 8:40 a.m. Feb. 3, 2014 - BusinessWire - BZX
Ignyta Appoints Matthew Onaitis as General Counsel 7:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Biogen Idec Foundation Awards Museum of Science $2.5 Million to Support Hall of Human Life 8:30 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia 1:00 a.m. Jan. 30, 2014 - BusinessWire - BZX
Biogen Idec 2013 Total Revenues Increase 26 Percent to $6.9 Billion 6:30 a.m. Jan. 29, 2014 - BusinessWire - BZX
RBCC Develops Innovations in White-Hot 3D Bioprinting Sector 4:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Critical Alerts For General Electric, SodaStream, Biogen Idec, Linn Energy, and Allscripts Released By InvestorsObserver 9:31 a.m. Jan. 24, 2014 - PR Newswire - PRF
RBCC Moves to the Front Lines of the 3D Bioprinting Revolution 5:00 a.m. Jan. 20, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....